These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36729971)

  • 1. Experiences of Health Departments on Community Engagement and Implementation of a COVID-19 Self-testing Program.
    Lane-Barlow C; Thomas I; Horter L; Fleurence R; Green J; Juluru K; Byrkit R; Weitz A; Ricaldi JN; Valencia D
    J Public Health Manag Pract; 2023 Jul-Aug 01; 29(4):539-546. PubMed ID: 36729971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study.
    Ciccone EJ; Conserve DF; Dave G; Hornik CP; Kuhn ML; Herling JL; Song M; Alston S; Singler L; Schmidt MD; Jones A; Broderick S; Wruck LM; Kibbe WA; Aiello AE; Woods CW; Richmond A; Cohen-Wolkowiez M; Corbie-Smith G
    BMC Public Health; 2021 Dec; 21(1):2209. PubMed ID: 34863144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based organization perspectives on participating in state-wide community canvassing program aimed to reduce COVID-19 vaccine disparities in California.
    Mansfield LN; Carson SL; Sunku N; Troutt A; Jackson S; Santillan D; Vassar SD; Slaughter D; Kim G; Norris KC; Brown AF
    BMC Public Health; 2023 Jul; 23(1):1356. PubMed ID: 37452299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-Based Testing Sites for SARS-CoV-2 - United States, March 2020-November 2021.
    Miller MF; Shi M; Motsinger-Reif A; Weinberg CR; Miller JD; Nichols E
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1706-1711. PubMed ID: 34882655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring barriers and facilitators of implementing an at-home SARS-CoV-2 antigen self-testing intervention: The Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) initiatives.
    Cross LM; DeFosset A; Yusuf B; Conserve D; Anderson R; Carilli C; Kibbe W; Cohen-Wolkowiez M; Richmond A; Corbie G; Dave G
    PLoS One; 2023; 18(11):e0294458. PubMed ID: 37971996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of COVID-19 self-testing and recommendations for implementation and scale-up among Black/African Americans: implications for the COVID-19 STEP project.
    Nwaozuru U; Obiezu-Umeh C; Diallo H; Graham D; Whembolua GL; Bourgeau MJ; Ritchwood TD; Nelson LE; Shato T; Mathews A; Moise R; Ward MC; Raude J; Ahonkhai AA; Young DJ; Conserve DF
    BMC Public Health; 2022 Jun; 22(1):1220. PubMed ID: 35725400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-engaged optimization of COVID-19 rapid evaluation and testing experiences: roll-out implementation optimization trial.
    Stadnick NA; Laurent LC; Cain KL; Seifert M; Burola ML; Salgin L; Watson P; Oswald W; Munoz FA; Velasquez SF; Smith JD; Zou J; Rabin BA
    Implement Sci; 2023 Oct; 18(1):46. PubMed ID: 37784200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with COVID-19 vaccine uptake in a US/Mexico border community: demographics, previous influenza vaccination, and trusted sources of health information.
    Lomeli A; Escoto AA; Reyes B; Burola MLM; Tinoco-Calvillo S; Villegas I; Cohen AS; Laurent LC; Salgin L; Stadnick NA; Rabin B; Seifert M
    Front Public Health; 2023; 11():1163617. PubMed ID: 37575117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engaging Community-Based Organizations to Address Barriers in Public Health Programs: Lessons Learned From COVID-19 Vaccine Acceptance Programs in Diverse Rural Communities.
    Evans D; Norrbom C; Schmidt S; Powell R; McReynolds J; Sidibe T
    Health Secur; 2023 Sep; 21(S1):S17-S24. PubMed ID: 37610883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on sexual and reproductive health self-care among women, healthcare providers, and other key informants: a mixed-methods study in South Africa and Zambia.
    Cartwright AF; Velarde M; Beksinska M; Smit J; Kasaro M; Tang JH; Milford C; Maphumulo V; Chinyama M; Chabu E; Mudenda M; Wong C; Fawzy M; Callahan R
    Reprod Health; 2023 Apr; 20(1):65. PubMed ID: 37118835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication to promote and support physical distancing for COVID-19 prevention and control.
    Ryan RE; Silke C; Parkhill A; Virgona A; Merner B; Hurley S; Walsh L; de Moel-Mandel C; Schonfeld L; Edwards AG; Kaufman J; Cooper A; Chung RKY; Solo K; Hellard M; Di Tanna GL; Pedrana A; Saich F; Hill S
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015144. PubMed ID: 37811673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-creating a Theory of Change to advance COVID-19 testing and vaccine uptake in underserved communities.
    Stadnick NA; Cain KL; Oswald W; Watson P; Ibarra M; Lagoc R; Ayers LO; Salgin L; Broyles SL; Laurent LC; Pezzoli K; Rabin B
    Health Serv Res; 2022 Jun; 57 Suppl 1(Suppl 1):149-157. PubMed ID: 35243622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation barriers and facilitators to a COVID-19 intervention in Bangladesh: The benefits of engaging the community for the delivery of the programme.
    Akter F; Tamim M; Saha A; Chowdhury IA; Faruque O; Talukder A; Chowdhury MAK; Patwary MM; Rahman AU; Chowdhury M; Sarker M
    BMC Health Serv Res; 2022 Dec; 22(1):1590. PubMed ID: 36578063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.
    Jimenez ME; Rivera-Núñez Z; Crabtree BF; Hill D; Pellerano MB; Devance D; Macenat M; Lima D; Martinez Alcaraz E; Ferrante JM; Barrett ES; Blaser MJ; Panettieri RA; Hudson SV
    JAMA Netw Open; 2021 Jul; 4(7):e2117074. PubMed ID: 34264327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key Stakeholder Perspectives of Community Engagement Efforts and the Impact of the Covid-19 Pandemic.
    Huang L; Cleveland T; Clift K; Egginton JS; Pacheco-Spann L; Johnson MG; Albertie M; Cardenas LD; Phelan SM; Allyse MA; Barwise AK
    J Prim Care Community Health; 2022; 13():21501319221133076. PubMed ID: 36331120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring COVID-19 Vaccine Attitudes among Racially and Ethnically Minoritized Communities: Community Partners' and Residents' Perspectives.
    Martinez Leal I; Njoh J; Chen TA; Foreman-Hays F; Reed BC; Haley SA; Chavez K; Reitzel LR; Obasi EM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of COVID-19 on the Delivery of Educational Programs in Native American Communities: Qualitative Study.
    Sacca L; Markham C; Hernandez B; Shegog R; Peskin M; Craig Rushing S; Warren H; Tsosie M
    JMIR Form Res; 2022 Apr; 6(4):e32325. PubMed ID: 35348464
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.